Interacting mediators of allostasis and allostatic load: Towards an understanding of resilience in aging

被引:253
作者
McEwen, BS [1 ]
机构
[1] Rockefeller Univ, Harold & Margaret Milliken Hatch Lab Neuroendocri, New York, NY 10021 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2003年 / 52卷 / 10期
关键词
D O I
10.1053/S0026-0495(03)00295-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Individual differences in the aging process can be conceptualized as an accumulation of wear and tear of daily experiences and major life stressors that interact with the genetic constitution and predisposing early life experiences. The neuroendocrine system, autonomic nervous system, and immune system are mediators of adaptation to challenges of daily life, referred to as allostasis, meaning "maintaining stability through change." Physiological mediators such as adrenalin from the adrenal medulla, glucocorticoids from the adrenal cortex, and cytokines from cells of the immune system act upon receptors in various tissues and organs to produce effects that are adaptive in the short run but can be damaging if the mediators are not shut off when no longer needed. When release of the mediators is not efficiently terminated, their effects on target cells are prolonged, leading to other consequences that may include receptor desensitization and tissue damage. This process has been named "allostatic load," and it refers to the price the tissue or organ pays for an overactive or inefficiently managed allostatic response. Therefore, allostatic load refers to the "cost" of adaptation. This article discusses the mediators of allostasis and their contributions to allostatic load as well as their role in resilience of the aging organism to stressful experiences. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:10 / 16
页数:7
相关论文
共 64 条
[1]   EFFECT OF DEHYDROEPIANDROSTERONE ON NEUROTRANSMITTER LEVELS AND APPETITE REGULATION OF THE OBESE ZUCKER RAT - THE OBESITY RESEARCH-PROGRAM [J].
ABADIE, JM ;
WRIGHT, B ;
CORREA, G ;
BROWNE, ES ;
PORTER, JR ;
SVEC, F .
DIABETES, 1993, 42 (05) :662-669
[2]  
Åberg MAI, 2000, J NEUROSCI, V20, P2896
[3]   Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats [J].
Aragno, M ;
Brignardello, E ;
Tamagno, E ;
Gatto, V ;
Danni, O ;
Boccuzzi, G .
JOURNAL OF ENDOCRINOLOGY, 1997, 155 (02) :233-240
[4]   DEHYDROPEPIANDROSTERONE FUNCTIONS AS MORE THAN AN ANTIGLUCOCORTICOID IN PRESERVING IMMUNOCOMPETENCE AFTER THERMAL-INJURY [J].
ARANEO, B ;
DAYNES, R .
ENDOCRINOLOGY, 1995, 136 (02) :393-401
[5]   Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects [J].
ArauzPacheco, C ;
Lender, D ;
Snell, PG ;
Huet, B ;
Ramirez, LC ;
Breen, L ;
Mora, P ;
Raskin, P .
AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (12) :1172-1178
[6]  
Arkins S, 2000, COPING ENV NEURAL EN, V4, P469
[7]   Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus [J].
Björntorp, P ;
Holm, G ;
Rosmond, R .
DIABETIC MEDICINE, 1999, 16 (05) :373-383
[8]   DEHYDROEPIANDROSTERONE ANTAGONIZES THE SUPPRESSIVE EFFECTS OF DEXAMETHASONE ON LYMPHOCYTE-PROLIFERATION [J].
BLAUER, KL ;
POTH, M ;
ROGERS, WM ;
BERNTON, EW .
ENDOCRINOLOGY, 1991, 129 (06) :3174-3179
[9]   Chronic fatigue syndrome: Identification of distinct subgroups on the basis of allergy and psychologic variables [J].
Borish, L ;
Schmaling, K ;
DiClementi, JD ;
Streib, J ;
Negri, J ;
Jones, JF .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (02) :222-230
[10]   DEHYDROEPIANDROSTERONE REGULATION OF THE HEPATIC GLUCOCORTICOID RECEPTOR IN THE ZUCKER RAT - THE OBESITY RESEARCH-PROGRAM [J].
BROWNE, ES ;
PORTER, JR ;
CORREA, G ;
ABADIE, J ;
SVEC, F .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1993, 45 (06) :517-524